KRAS and colorectal cancer: Moreover, these metabolic changes observed in G12D and G12V SW48 cells show striking similarities to the consensus molecular subtype 3 (CMS3) of colorectal cancer types, which show an association between increased KRAS mutations and elevated metabolic signature of glutamine and nitrogen metabolism (Guinney et al, 2015).